Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice
- PMID: 25111852
- DOI: 10.1016/j.intimp.2014.07.010
Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with high mortality and poor prognosis. Previous studies confirmed that NF-κB plays a critical role in the pathogenesis of pulmonary fibrosis and glucagon like peptide-1 (GLP-1) has a property of anti-inflammation by inactivation of NF-κB. Furthermore, the GLP-1 receptor was detected in the lung tissues. Our aim was to investigate the potential value and mechanisms of GLP-1 on BLM-induced pulmonary fibrosis in mice. Mice with BLM-induced pulmonary fibrosis were treated with or without GLP-1 administration. 28 days after BLM infusion, the number of total cells, macrophages, neutrophils, lymphocytes, and the content of TGF-β1 in BALF were measured. Hematoxylin-eosin (HE) staining and Masson's trichrome (MT) staining were performed. The Ashcroft score and hydroxyproline content were analyzed. RT-qPCR and western blot were used to evaluate the expression of α-SMA and VCAM-1. The phosphorylation of NF-κB p65 was also assessed by western blot. DNA binding of NF-κB p65 was measured through Trans(AM) p65 transcription factor ELISA kit. GLP-1 reduced inflammatory cell infiltration and the content of TGF-β1 in BLAF in mice with BLM injection. The Ashcroft score and hydroxyproline content were decreased by GLP-1 administration. Meanwhile, BLM-induced overexpression of α-SMA and VCAM-1 were blocked by GLP-1 treatment in mice. GLP-1 also reduced the ratio of phosphor-NF-κB p65/total-NF-κB p65 and NF-κB p65 DNA binding activity in BLM-induced pulmonary fibrosis in mice. Our data found that BLM-induced lung inflammation and pulmonary fibrosis were significantly alleviated by GLP-1 treatment in mice, possibly through inactivation of NF-κB.
Keywords: Glucagon like peptide-1; Inflammation; Nuclear factor-kappa B; Pulmonary fibrosis; Transforming growth factor-beta1.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
[The Study of the Effect and Mechanism of Glucagon Like Peptide-1 in Bleomycin-induced Pulmonary Fibrosis in Mice].Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 Jul;48(4):509-514. Sichuan Da Xue Xue Bao Yi Xue Ban. 2017. PMID: 28752966 Chinese.
-
Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.Int J Mol Sci. 2013 Dec 3;14(12):23581-96. doi: 10.3390/ijms141223581. Int J Mol Sci. 2013. PMID: 24300094 Free PMC article.
-
[Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].Zhonghua Yi Xue Za Zhi. 2007 Jan 16;87(3):195-9. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17425852 Chinese.
-
Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions.Pharmacol Res. 2015 Jul;97:122-30. doi: 10.1016/j.phrs.2015.04.012. Epub 2015 May 8. Pharmacol Res. 2015. PMID: 25959210 Review.
-
Effects of plant extracts and bioactive compounds on attenuation of bleomycin-induced pulmonary fibrosis.Biomed Pharmacother. 2018 Nov;107:1454-1465. doi: 10.1016/j.biopha.2018.08.111. Epub 2018 Sep 3. Biomed Pharmacother. 2018. PMID: 30257362 Review.
Cited by
-
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND).Front Pharmacol. 2024 Sep 4;15:1457363. doi: 10.3389/fphar.2024.1457363. eCollection 2024. Front Pharmacol. 2024. PMID: 39318780 Free PMC article.
-
Diabetes Mellitus Contributes to Idiopathic Pulmonary Fibrosis: A Review From Clinical Appearance to Possible Pathogenesis.Front Public Health. 2020 Jun 3;8:196. doi: 10.3389/fpubh.2020.00196. eCollection 2020. Front Public Health. 2020. PMID: 32582606 Free PMC article. Review.
-
Liraglutide pretreatment attenuates sepsis-induced acute lung injury.Am J Physiol Lung Cell Mol Physiol. 2023 Sep 1;325(3):L368-L384. doi: 10.1152/ajplung.00041.2023. Epub 2023 Jul 25. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 37489855 Free PMC article.
-
Glucagon-like peptide-1 receptor mediates the beneficial effect of liraglutide in an acute lung injury mouse model involving the thioredoxin-interacting protein.Am J Physiol Endocrinol Metab. 2020 Sep 1;319(3):E568-E578. doi: 10.1152/ajpendo.00292.2020. Epub 2020 Jul 29. Am J Physiol Endocrinol Metab. 2020. PMID: 32723174 Free PMC article.
-
Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling.Naunyn Schmiedebergs Arch Pharmacol. 2016 Oct;389(10):1103-15. doi: 10.1007/s00210-016-1277-8. Epub 2016 Jul 16. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27424158
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous